Skip to main content

Table 2 H. pylori genotypes

From: Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?

Genotype

Group A

Group B

(n = 103)

(n = 51)

cagA positive

44 (42.7%)

10 (19.6%)

vacA s1m1

24 (23.3%)

4 (7.8%)

vacA s1m2

28 (27.2%)

12 (23.5%)

vacA s2m1

1 (1%)

2 (3.9%)

vacA s2m2

50 (48.5%)

33 (64.7%)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us